INVA FY 2020 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$337M+29.0% YoY

Gross Profit

$337M100.0% margin

Operating Income

$321M95.3% margin

Net Income

$224M66.6% margin

EPS (Diluted)

$2.02

Cash Flow

Operating Cash Flow

$313M

Free Cash Flow

$313M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$1000M

Total Liabilities

$392M

Stockholders' Equity

$540M

Cash & Equivalents

$246M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$337M	$261M	+29.0%
Gross Profit	$337M	$261M	+29.0%
Operating Income	$321M	$246M	+30.3%
Net Income	$224M	$157M	+42.7%